Jounce Therapeutics, Inc.
(NASDAQ) JNCE
Jounce Therapeutics, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$82.00M
Net Income (TTM)
$50.92M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
JNCE News
2018 ASCO Conference Roundup
JNCE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jounce Therapeutics, Inc.
Industry
Biotechnology
Sector
Health CareEmployees
141
CEO
Richard Murray, PhD
Website
www.jouncetx.comHeadquarters
Cambridge, MA 02139, US
JNCE Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-64%
Net Income Margin
-62%
Return on Equity
-25%
Return on Capital
-28%
Return on Assets
-24%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$82.00M
Operating Income
$52.24M
EBITDA
$50.16M
Operating Cash Flow
$28.88M
Capital Expenditure
$919.00K
Free Cash Flow
$29.80M
Cash & ST Invst.
$189.54M
Total Debt
$10.02M
Jounce Therapeutics, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$82.00M
+304753309.9%
Gross Profit
$82.00M
+304753309.9%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
141
N/A
Net Income
$50.96M
+169752.0%
EBITDA
$50.78M
+7445.5%
Quarterly Fundamentals
Net Cash
$179.52M
+11.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.87M
-41.3%
Short Term Debt
$4.15M
-43.8%
Return on Assets
-23.96%
N/A
Return on Invested Capital
-27.64%
N/A
Free Cash Flow
$59.01M
+308.3%
Operating Cash Flow
$59.23M
+310.0%